Kaplan–Meier analysis of specimens from HNSCC patients revealed that patients with low CCL2 protein levels had longer disease-specific survival (DSS) than patients with high CCL2 protein levels (Fig. 1C). The gene discussed is CCL2; the disease is head and neck squamous cell carcinoma.